Hypoxia- and Anoikis-Related lncRNA Signature Defines Molecular Subtypes and Predicts Prognosis and Immunotherapy Response in Hepatocellular Carcinoma [Corrigendum]

Lu X, Wang Y, Yu Y, et al. J Hepatocell Carcinoma. 2025;12:2307—2325. The authors have advised that they neglected to include a funding statement on page 2323 of the published paper. The funding statement should read as follows. FundingThis study was supported by the National Natural Science Foundation of China (No. 82160829), the Guangxi Zhuang Autonomous Region Natural Science Foundation (Nos. 2025GXNSFDA069035 and 2025GXNSFAA069372), the Project of Inheritancing Studio Construction about 2024 Guangxi Famous Traditional Chinese Medicine (No. GZY2024012), the Qihuang High-Level Talent Team Project (No. 2202409), the Guipai Xinglin Top-Talent Project (No. 202202), and the Third Batch of Qihuang High-Level Talent Team Project of Guangxi University of Chinese Medicine (No. 202411). The authors apologize for this error.